Publicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (20)

2024

  1. Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study

    International Journal of Cancer, Vol. 154, Núm. 9, pp. 1596-1606

2023

  1. Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study

    British Journal of Cancer, Vol. 128, Núm. 8, pp. 1529-1540

  2. Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study

    Free Radical Biology and Medicine, Vol. 209, pp. 381-393

  3. Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients

    International Journal of Cancer, Vol. 152, Núm. 11, pp. 2257-2268

2022

  1. Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations

    BMC Cancer, Vol. 22, Núm. 1

2021

  1. Dietary advanced glycation end-products and colorectal cancer risk in the European prospective investigation into cancer and nutrition (EPIC) study

    Nutrients, Vol. 13, Núm. 9

  2. Dietary intake of advanced glycation end products (Ages) and mortality among individuals with colorectal cancer

    Nutrients, Vol. 13, Núm. 12

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  2. Precision prevention and cancer interception: The new challenges of liquid biopsy

    Cancer Discovery, Vol. 10, Núm. 11, pp. 1635-1644

2018

  1. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence

    Nature Communications, Vol. 9, Núm. 1

  2. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations

    PLoS ONE, Vol. 13, Núm. 1

  3. Identification of FAM173B as a protein methyltransferase promoting chronic pain

    PLoS Biology, Vol. 16, Núm. 2

  4. The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling

    Oncotarget, Vol. 9, Núm. 15, pp. 12201-12211

2016

  1. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

    Nature Communications, Vol. 7

2014

  1. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

    American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61

  2. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 24, pp. 8838-8843

2013

  1. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci

    Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029

2012

  1. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23

    Human Molecular Genetics, Vol. 21, Núm. 2, pp. 456-462

2011

  1. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

    Nature Genetics, Vol. 43, Núm. 1, pp. 60-65